Bio-Techne (TECH) Reports In-Line Q3 EPS

Bio-Techne (NASDAQ: TECH) reported Q3 EPS of $0.53, in-line with the analyst estimate of $0.53. Revenue for the quarter came in at $294.1 million versus the consensus estimate of $296.61 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Barclays says AI trade is maturing, favors greater diversification
• Arrive AI and DXC Technology partner to bring delivery tech to factories